Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on ...

Insulet Corp., manufacturer of the tubeless Omnipod Insulin Management System, has been awarded $452 million in damages after it successfully defended its intellectual property against ...

在市场信心的显著表现下，Insulet Corporation（股票代码：PODD）的股价创下了新的52周高点，股价峰值达到279.42美元。根据 InvestingPro ...

Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

Insulet公司（纳斯达克股票代码：PODD）的集团副总裁、首席会计官兼财务总监Lauren Budden最近出售了部分公司股份。Insulet是一家市值192亿美元的医疗设备公司，其股票在过去六个月内上涨了43%。根据最近的SEC文件显示，Budden于2024年12月10日以每股275.62美元的价格出售了915股Insulet普通股。此次交易的总价值为252,192美元。

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch when President-elect ...

After hours: December 11 at 6:55:59 PM EST Loading Chart for PODD ...

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

After hours: 4 December at 6:22:54 pm GMT-5 ...